Brief: Cantargia Reports Advantages Of Nadunolimab Mechanism Of Action

Cantargia AB

30/08/2021 15:46

Aug 30 (Reuters) - Cantargia AB  CANTA.ST :
    * CANTARGIA REPORTS PRECLINICAL DATA HIGHLIGHTING ADVANTAGES
OF
NADUNOLIMAB MECHANISM OF ACTION
    * CAN04 INCREASED ANTI-TUMOR EFFECT OF DOCETAXEL

Source text for Eikon:  ID:nNDL2dfvK3 
Further company coverage:  CANTA.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))